Clinical ScienceThe safety of low molecular-weight heparin after blunt liver and spleen injuries
Section snippets
Methods
After institutional review board approval, a retrospective review of all blunt liver and spleen injuries was performed at 2 academic level 1 trauma centers, the University of South Alabama and the University of Mississippi Medical Center. Data were collected for all blunt trauma patients admitted during years 2007 through 2011 who underwent NOM of liver and/or splenic injuries. All patients received routine prophylactic anticoagulation with LMWH (enoxaparin). Collected data included date and
Results
Three hundred fifty-five patients with blunt spleen or liver injuries were identified from the study period, 172 from the University of South Alabama and 183 from the University of Mississippi. Three hundred twenty-eight of these patients had complete information concerning LMWH administration. One hundred three patients (31%) received LMWH early, 54 (17%) in the intermediate group, and 171 patients (52%) were in the late administration group (Table 1, Table 2). All patients had an initial
Comment
In this retrospective study investigating the safety of administration of LMWH in patients with solid organ injury, there were no failures of NOM in patients who received LMWH in any group. Also, there was no difference in the amount of blood products administered or bleeding complications from any group. VTE complications were higher in the patients that received LMWH more than 72 hours after hospital admission, suggesting that early chemical VTE prophylaxis may be beneficial in trauma
Conclusion
Early use of prophylactic LMWH does not appear to increase NOM failure rates or blood transfusion requirements in this cohort. Therefore, early administration of LMWH may decrease the incidence of VTE in patients with blunt solid organ injury without incurring the risk of hemorrhagic complications. Further prospective investigation is warranted to confirm the safety and optimal timing of early prophylactic LMWH administration in patients with high-grade blunt solid organ injuries.
Acknowledgments
Jon Simmons is the principal investigator and contributed toward study design, data collection, and manuscript development. Justin Manley contributed toward study design, data collection, and manuscript revisions. Jack Rostas contributed toward statistical analysis, data collection, and manuscript development. Richard Gonzalez contributed toward manuscript development and revisions. Sidney Brevard contributed toward manuscript revisions. Naveed Ahmed contributed toward study design, and
References (18)
- et al.
Prevention of venous thromboembolism
Chest
(2001) - et al.
A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients
J Am Coll Surg
(2001) - et al.
Surveillance venous duplex is not clinically useful after total joint arthroplasty when effective deep venous thrombosis prophylaxis is used
Ann Vasc Surg
(2004) - et al.
Thromboprophylaxis for trauma patients
Cochrane Database Syst Rev
(2013) - et al.
Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group
J Trauma
(2002) Prevention of venous thromboembolism in trauma and long bone fractures
Curr Opin Pulm Med
(2001)- et al.
Pulmonary embolism in major trauma patients
J Trauma
(1990) - et al.
Use of low molecular weight heparin in preventing thromboembolism in trauma patients
J Trauma
(1996) - et al.
Venous thromboembolism after trauma
Curr Opin Crit Care
(2004)
Cited by (33)
Hybrid repair of an innominate artery pseudoaneurysm after blunt traumatic injury in a bovine arch
2023, Journal of Vascular Surgery Cases, Innovations and TechniquesTiming of venous thromboembolism chemoprophylaxis using objective hemoglobin criteria in blunt solid organ injury
2023, InjuryCitation Excerpt :As there is a clinically significant increase in VTE events between the 24 h and 48 h mark, it is clear that initiation of prophylaxis should be started as early as possible. Utilizing our guideline, we were able to start blunt injured patients just as early if not earlier than other published cohorts. [19–28] Ongoing study at our institution is being performed to determine whether a shorter time interval would be both safe and more efficacious.
Thromboprophylaxis Timing After Blunt Solid Organ Injury: A Systematic Review and Meta-analysis
2023, Journal of Surgical ResearchVenous thromboembolic events: Diagnosis, treatment, and filters as adjuncts
2023, Current Therapy of Trauma and Surgical Critical CareEarly Venous Thromboembolism Prophylaxis for Isolated High-Grade Blunt Splenic Injury
2019, Journal of Surgical ResearchCitation Excerpt :To date, several small retrospective studies in the last 15 y have shown the safety of early administration of VTE prophylaxis within 48 to 72 h of admission. However, the vast majority of patients in those studies sustained low-grade (grades 1-2) injuries.10-16 In addition, the timing of VTE prophylaxis can be influenced by other associated injuries, such as traumatic brain injury.
Timing of venous thromboprophylaxis in isolated severe pelvic fracture: Effect on mortality and outcomes
2019, InjuryCitation Excerpt :In a retrospective study of 705 patients with blunt spine trauma requiring operative stabilization, PE rates were significantly lower in patients that consistently received preoperative VTE prophylaxis [10]. Rostas et al, in a 5 year retrospective study of patients with blunt liver and spleen injuries, found that early pharmacologic prophylaxis with LMWH was safe and associated with lower rates of VTE [11]. No studies have been published addressing the timing and type of prophylaxis in pelvic fractures.
All authors participated in the analysis and interpretation of data.
Dr Simmons is supported by the American College Surgeons Clowes Award and the American Heart Association (14CRP19010032). The other authors declare no conflicts of interest.